Chrysophanol 8-O-glucosideCAS# 13241-28-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 13241-28-6 | SDF | Download SDF |
PubChem ID | 442731 | Appearance | Orange powder |
Formula | C21H20O9 | M.Wt | 416.4 |
Type of Compound | Anthraquinones | Storage | Desiccate at -20°C |
Synonyms | Pulmatin | ||
Solubility | Soluble in DMSO and methan | ||
Chemical Name | 1-hydroxy-3-methyl-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione | ||
SMILES | CC1=CC(=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)OC4C(C(C(C(O4)CO)O)O)O)O | ||
Standard InChIKey | WMMOMSNMMDMSRB-JNHRPPPUSA-N | ||
Standard InChI | InChI=1S/C21H20O9/c1-8-5-10-14(11(23)6-8)18(26)15-9(16(10)24)3-2-4-12(15)29-21-20(28)19(27)17(25)13(7-22)30-21/h2-6,13,17,19-23,25,27-28H,7H2,1H3/t13-,17-,19+,20-,21-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Chrysophanol-8-O-beta-D-glucopyranoside and chrysophanol have mild cytotoxicity and anti-diabetic properties and can play metabolic roles in the insulin-stimulated glucose transport pathway; it has potent inhibitory effect on collagen- and thrombin-induced platelet aggregation, it only inhibits platelet phosphatidylserine exposure.Chrysophanol-8-O-beta-D-glucopyranoside also exhibits significant anti-HBV activities with improved liver function, and enhanced HBeAg and HBsAg sero-conversion rates as well as HBV DNA clearance rates in HepG2 2.2.15 cells, DHBV models, or patients with chronic hepatitis B (CHB). |
Targets | HBV | GLUT |
In vitro | Chrysophanol-8-O-glucoside, an anthraquinone derivative in rhubarb, has antiplatelet and anticoagulant activities.[Pubmed: 22302018]J Pharmacol Sci. 2012;118(2):245-54.Rhubarb is a widely used traditional medicine and has been reported to elicit a number of biological effects including anti-inflammatory and antiplatelet effects. In the present study, we investigated the effects of anthraquinone derivatives isolated from rhubarb on platelet activity. Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection.[Pubmed: 24423652]Drug Discov Ther. 2013 Dec;7(6):212-24.Over a long period of time in clinical practice and in basic research progress, the effectiveness and beneficial contribution of TCM on CHB have been gradually known and confirmed. |
Kinase Assay | Anti-diabetic properties of chrysophanol and its glucoside from rhubarb rhizome.[Pubmed: 18981591]Biol Pharm Bull. 2008 Nov;31(11):2154-7.An ethanol extract of rhubarb rhizome exhibited marked glucose transport activity in differentiated L6 rat myotubes. Activity-guided fractionation resulted in the isolation of two anthraquinones, chrysophanol-8-O-beta-D-glucopyranoside (Chrysophanol 8-O-glucoside,1) and chrysophanol (2). |
Chrysophanol 8-O-glucoside Dilution Calculator
Chrysophanol 8-O-glucoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4015 mL | 12.0077 mL | 24.0154 mL | 48.0307 mL | 60.0384 mL |
5 mM | 0.4803 mL | 2.4015 mL | 4.8031 mL | 9.6061 mL | 12.0077 mL |
10 mM | 0.2402 mL | 1.2008 mL | 2.4015 mL | 4.8031 mL | 6.0038 mL |
50 mM | 0.048 mL | 0.2402 mL | 0.4803 mL | 0.9606 mL | 1.2008 mL |
100 mM | 0.024 mL | 0.1201 mL | 0.2402 mL | 0.4803 mL | 0.6004 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- β-D-Glucopyranoside,(3β,6α,16β,20R,24S)-3-[(3,4-di-O-acetyl-β-D-xylopyranosyl)oxy]-20, 24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl
Catalog No.:BCC8370
CAS No.:1324005-51-7
- TC-G 1006
Catalog No.:BCC6277
CAS No.:1324003-64-6
- Boc-Gln(Trt)-OH
Catalog No.:BCC3384
CAS No.:132388-69-3
- Boc-Asn(Trt)-OH
Catalog No.:BCC3360
CAS No.:132388-68-2
- Fmoc-Gln(Trt)-OPfp
Catalog No.:BCC3486
CAS No.:132388-65-9
- Fmoc-Asn(Trt)-OPfp
Catalog No.:BCC3082
CAS No.:132388-64-8
- Z-Gln(Trt)-OH
Catalog No.:BCC2782
CAS No.:132388-60-4
- Fmoc-Asn(Trt)-OH
Catalog No.:BCC3081
CAS No.:132388-59-1
- H-Asn(Trt)-OH
Catalog No.:BCC2878
CAS No.:132388-58-0
- 10-Hydroxyneoline
Catalog No.:BCN6510
CAS No.:132362-42-6
- 5-Acetoxy-7-hydroxyflavone
Catalog No.:BCN6174
CAS No.:132351-58-7
- Methyl isocostate
Catalog No.:BCN6173
CAS No.:132342-55-3
- Neoeriocitrin
Catalog No.:BCN3271
CAS No.:13241-32-2
- Neohesperidin
Catalog No.:BCN5915
CAS No.:13241-33-3
- Alosetron-d3 Hydrochloride
Catalog No.:BCC1345
CAS No.:1189919-71-8
- 2-TEDC
Catalog No.:BCC6735
CAS No.:132465-10-2
- (Z)-Pugnac
Catalog No.:BCC5333
CAS No.:132489-69-1
- Olanzapine
Catalog No.:BCC5042
CAS No.:132539-06-1
- 15-Demethylplumieride
Catalog No.:BCN6176
CAS No.:132586-69-7
- Bruceanic acid C
Catalog No.:BCN7999
CAS No.:132587-60-1
- CCMQ
Catalog No.:BCC6984
CAS No.:132623-44-0
- Otophylloside O
Catalog No.:BCN7337
CAS No.:1326583-08-7
- Senecionine N-oxide
Catalog No.:BCN2130
CAS No.:13268-67-2
- Fmoc-Tle-OH
Catalog No.:BCC2657
CAS No.:132684-60-7
Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection.[Pubmed:24423652]
Drug Discov Ther. 2013 Dec;7(6):212-24.
Since the significant public health hazard of Hepatitis B virus (HBV) infection and obvious drug resistance and dose-dependent side effects for common antiviral agents (e.g., interferon alpha, lamivudine, and adefovir), continuous development of agents to treat HBV infection is urgently needed. Traditional Chinese medicine (TCM) is an established segment of the health care system in China. Currently, it is widely used for chronic hepatitis B (CHB) in China and many parts of the world. Over a long period of time in clinical practice and in basic research progress, the effectiveness and beneficial contribution of TCM on CHB have been gradually known and confirmed. Based upon our review of related papers and because of our prior knowledge and experience, we have selected some Chinese medicines, including Chinese herbal formulas (e.g., Xiao-Chai-Hu-Tang, Xiao-Yao-San, and Long-Dan-Xie-Gan-Tang), single herbs (e.g., Phyllanthus niruri, Radix astragali, Polygonum cuspidatum, Rheum palmatum, and Salvia miltiorrhiza) and related active compounds (e.g., wogonin, artesunate, saikosaponin, astragaloside IV, and chrysophanol 8-O-beta-Dglucoside) and Chinese medicine preparations (e.g., silymarin, silibinin, kushenin, and cinobufacini), which seem effective and worthy of additional and indepth study in treating CHB, and we have given them a brief review. We conclude that these Chinese herbal medicines exhibit significant anti-HBV activities with improved liver function, and enhanced HBeAg and HBsAg sero-conversion rates as well as HBV DNA clearance rates in HepG2 2.2.15 cells, DHBV models, or patients with CHB. We hope this review will contribute to an understanding of TCM and related active compounds as an effective treatment for CHB and provide useful information for the development of more effective antiviral drugs.
Anti-diabetic properties of chrysophanol and its glucoside from rhubarb rhizome.[Pubmed:18981591]
Biol Pharm Bull. 2008 Nov;31(11):2154-7.
An ethanol extract of rhubarb rhizome exhibited marked glucose transport activity in differentiated L6 rat myotubes. Activity-guided fractionation resulted in the isolation of two anthraquinones, chrysophanol-8-O-beta-D-glucopyranoside (1) and chrysophanol (2). The anti-diabetic effect was examined by glucose transport activity, glucose transporter 4 (Glut4) expression in myotubes, and the level of insulin receptor (IR) tyrosine phosphorylation as influenced by tyrosine phosphatase 1B, each of which is a major target of diabetes treatment. Chrysophanol-8-O-beta-D-glucopyranoside up to 25 microM dose-dependently activated glucose transport in insulin-stimulated myotubes. Increased tyrosine phosphorylation of IR due to tyrosine phosphatase 1B inhibitory activity with an IC50 value of 18.34+/-0.29 microM and unchanged Glut4 mRNA levels was observed following chrysophanol-8-O-beta-D-glucopyranoside treatment. Chrysophanol up to 100 microM exerted mild glucose transport activity and elevated the tyrosine phosphorylation of IR via tyrosine phosphatase 1B inhibition (IC50=79.86+/-0.12 microM); Glut4 mRNA expression was also significantly increased by 100 microM. The ED50 values of the two compounds were 59.38+/-0.66 and 79.69+/-0.03 microM, respectively. Therefore, these two anthraquinones from rhubarb rhizome, chrysophanol-8-O-beta-D-glucopyranoside and chrysophanol, have mild cytotoxicity and anti-diabetic properties and could play metabolic roles in the insulin-stimulated glucose transport pathway.
Chrysophanol-8-O-glucoside, an anthraquinone derivative in rhubarb, has antiplatelet and anticoagulant activities.[Pubmed:22302018]
J Pharmacol Sci. 2012;118(2):245-54. Epub 2012 Feb 3.
Rhubarb is a widely used traditional medicine and has been reported to elicit a number of biological effects including anti-inflammatory and antiplatelet effects. In the present study, we investigated the effects of anthraquinone derivatives isolated from rhubarb on platelet activity. Of four anthraquinone derivatives isolated from rhubarb examined, chrysophanol-8-O-glucoside (CP-8-O-glc) was found to have the most potent inhibitory effect on collagen- and thrombin-induced platelet aggregation. CP-8-O-glc-treated mice showed significantly prolonged bleeding times. Furthermore, CP-8-O-glc was found to have a significant inhibitory effect on rat platelet aggregation ex vivo and on thromboxane A(2) formation in vitro. In coagulation tests, CP-8-O-glc did not alter prothrombin time, and it prolonged the activated partial thromboplastin time. However, CP-8-O-glc only inhibited platelet phosphatidylserine exposure, but not exert direct inhibition on intrinsic factors. This study demonstrates the antiplatelet and anticoagulant effects of CP-8-O-glc and suggests that this compound might be of therapeutic benefit for the prevention of platelet-related cardiovascular diseases.